Effects of Losartan on Hepatic Fibrogenesis in Chronic Hepatitis C

NCT00298714 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis C
Liver Fibrosis

Interventions

DRUG: Losartan

Sponsor

Hospital Clinic of Barcelona